Page 30

Polk BF, Modin JF, White JA, DeGirolami PC. 1982. A controlled comparison of joint reactions among women receiving one of two rubella vaccines. American Journal of Epidemiology 115:19-25.

Preblud SR. 1985. Some current issues relating to rubella vaccine. Journal of the American Medical Association 254:253-256.

Preston NW, Surapatana N, Carter EJ. 1982. A reappraisal of serotype factors 4, 5, and 6 of Bordetella pertussis. Journal of Hygiene 88:39-46.

Public Health Service. 1986. Pertussis and Pertussis Vaccine in Japan. Report of the U.S. Public Health Service Interagency Group to Monitor Vaccine Development, Production, and Usage. Unpublished.

Rodgers GC Jr., Badgett T. 1985. Evaluation of the safety and immunogenicity of a new DTP vaccine containing an acellular pertussis component in 4-6 year old children. Pediatric Research 19:208A.

Rowlands DF, Freestone DS. 1971. Vaccination against rubella of susceptible schoolgirls in Reading. Journal of Hygiene 69:579-586.

Sato Y, Cowell JL, Sato H, Burstyn DG, Manclark CR. 1983. Separation and purification of the hemagglutinins from Bordetella pertussis. Infection and Immunity 41:313-320.

Sato Y, Kimura M, Fukumi H. 1984. Development of a pertussis component vaccine in Japan. Lancet 1:122-126.

Sauer L. 1933a. Whooping cough: a study in immunization. Journal of the American Medical Association 101:239-241.

Sauer L. 1933b. Immunization with bacillus pertussis vaccine. Journal of the American Medical Association 101:1449-1451.

Schaffner W, Fleet WF, Kilroy AW, Lefkowitz LB, Herrmann KL, Thompson J, Karzon DT. 1974. Polyneuropathy following rubella immunization. American Journal of Diseases of Children 127:684-688.

Scheie HG, Schaffer DB, Plotkin SA, Kertesz ED. 1967. Congenital rubella cataracts. Archives of Ophthalmology 77:440-444.

Schlossberg D, Topolsky MK. 1977. Military rubella. Journal of the American Medical Association 238:1273-1274.

Seth P, Manjunath N, Balaya S. 1985. Rubella infection: the Indian scene. Reviews of Infectious Diseases 7:S64-S67.

Shahin RD, Brennan MJ, Li ZM, Meade BD, Manclark CR. 1990. Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis. Journal of Experimental Medicine 171:63-73.

Sherman EF, Michaels RH, Kenny FM. 1965. Acute encephalopathy (encephalitis) complicating rubella: report of cases with virologic studies, cortisol-production determinations and observations at autopsy. Journal of the American Medical Association 192:675-681.

Spruance SL, Smith CB. 1971. Joint complications associated with derivatives of HPV-77 rubella virus vaccine. American Journal of Diseases of Children 122:105-111.

Stallybrass CO. 1931. The Principles of Epidemiology and the Process of Infection. New York: The Macmillan Co.

Storsaeter J, Hallander HO, Farrington CP. 1990. Evaluation of laboratory methods used for the diagnosis of pertussis infection and disease in the Vaccine Efficacy Trial in Sweden. In: Manclark CR, ed. Sixth International Symposium on Pertussis, Abstracts. DHHS Publication No. (FDA) 90-1162. Bethesda, MD: Public Health Service, U.S. Department of Health and Human Services.

Swartz TA, Klingberg W, Goldwasser RA, Klingberg MA, Goldblum N, Hilleman MR. 1971. Clinical manifestations, according to age, among females given HPV-77 duck rubella vaccine. American Journal of Epidemiology 94:246-251.

Tingle AJ. 1990. Evidence linking rubella vaccines to chronic arthritis. Presentation for Insti-